Ovid Therapeutics, Inc. (OVID)
1.62
+0.05
(+3.18%)
USD |
NASDAQ |
Dec 10, 16:00
1.58
-0.04
(-2.47%)
Pre-Market: 09:15
Ovid Therapeutics Profit Margin (Quarterly): -9.21K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AnaptysBio, Inc. | 19.80% |
| Ionis Pharmaceuticals, Inc. | -82.06% |
| MannKind Corp. | 9.72% |
| Cassava Sciences, Inc. | -- |
| Cidara Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -59.70% |
| Return on Assets | -43.48% |
| Return on Invested Capital | -48.14% |
| Gross Profit Margin (Quarterly) | 87.12% |
| Operating Margin (Quarterly) | -9.49K% |
| Return on Net Operating Assets | -281.0% |